Synthroid Cost in Pennsylvania 2026: Prices, Insurance, and Savings

Prescription access and medication affordability image for Synthroid Cost in Pennsylvania 2026: Prices, Insurance, and Savings

At a glance

  • Brand Synthroid manufacturer list price / approximately $50 per month
  • Generic levothyroxine average cash price in PA / roughly $15 per month
  • Pennsylvania Medicaid status / covered with prior authorization
  • Compounded levothyroxine via 503A pharmacies / available in Pennsylvania
  • Standard dosing / once daily, oral tablet, on an empty stomach
  • Telehealth prescribing in PA / permitted under state law
  • Common starting dose for adults / 1.6 mcg per kg body weight per day
  • TSH recheck interval after dose change / 6 to 8 weeks

What Brand-Name Synthroid Costs in Pennsylvania

The manufacturer list price for Synthroid, made by AbbVie, sits near $50 per month for most tablet strengths. That figure represents the wholesale acquisition cost before any insurance negotiation, pharmacy benefit manager rebate, or discount card. Pennsylvania patients without insurance can expect to pay between $35 and $55 at most chain pharmacies for a 30-day supply of brand Synthroid, depending on the dose prescribed.

Retail Price Variation Across PA Pharmacies

Pricing varies by pharmacy chain, independent pharmacy, and region within the state. A CVS in Philadelphia may charge a different cash price than a Rite Aid in Pittsburgh for the identical 100 mcg tablet. Calling two or three local pharmacies before filling a prescription is one of the fastest ways to find a lower price without changing the medication itself.

Why Brand vs. Generic Matters for Thyroid Drugs

The American Thyroid Association (ATA) 2014 guidelines recommend that patients remain on the same levothyroxine formulation once their TSH has stabilized, because small differences in bioavailability between manufacturers can shift thyroid hormone levels 1. The FDA classifies levothyroxine as a narrow therapeutic index drug 2, meaning even minor variations in absorbed dose can produce clinically meaningful changes in TSH. If your physician specifically writes "brand medically necessary" on the prescription, pharmacies in Pennsylvania must dispense brand Synthroid rather than substituting a generic.

Generic Levothyroxine Prices in Pennsylvania

Generic levothyroxine costs roughly $15 per month at Pennsylvania retail pharmacies for a standard 30-day supply without insurance. That price has stayed relatively flat since 2024, when generic competition among manufacturers like Mylan, Sandoz, and Lannett helped keep wholesale costs low 3. Generic levothyroxine sodium tablets are AB-rated to Synthroid by the FDA, confirming bioequivalence within accepted limits 4.

How to Pay Even Less for Generic

Pharmacy discount programs from GoodRx, RxSaver, and Amazon Pharmacy can push the out-of-pocket cost for generic levothyroxine below $10 per month at select Pennsylvania locations. These programs are not insurance; they are negotiated discount rates that apply at the pharmacy counter. Patients should confirm with their pharmacist that the discount card price is lower than their insurance copay before using one, because using a card instead of insurance means the purchase does not count toward their annual deductible.

90-Day Supply Savings

Mail-order pharmacies and 90-day retail fills often reduce per-tablet cost by 20 to 30 percent. Pennsylvania law permits 90-day dispensing for maintenance medications, and most insurers operating in the state cover this option. A 90-day supply of generic levothyroxine through a mail-order pharmacy can cost $25 to $35 total, compared with roughly $45 for three separate 30-day fills at retail.

Pennsylvania Medicaid Coverage for Synthroid and Levothyroxine

Pennsylvania Medicaid, administered through managed care organizations like AmeriHealth Caritas, Geisinger Health Plan, and UPMC for You, covers levothyroxine with prior authorization. Generic levothyroxine is typically on the preferred drug list, meaning it requires no prior authorization and carries a $0 to $3 copay for most enrollees 5. Brand Synthroid may require a prior authorization showing medical necessity, such as documented TSH instability after a generic switch.

Who Qualifies for PA Medicaid

Pennsylvania expanded Medicaid under the Affordable Care Act in 2015. Adults earning up to 138% of the federal poverty level qualify for coverage. Hypothyroidism is among the most common endocrine conditions in the United States, affecting approximately 4.6% of the population aged 12 and older 6, and levothyroxine consistently ranks as one of the most prescribed medications nationally 7. Pennsylvania Medicaid formularies reflect that prevalence by keeping generic levothyroxine accessible with minimal barriers.

Medicaid Managed Care Organization Differences

Each MCO in Pennsylvania maintains its own preferred drug list. A drug that sits on the preferred tier for AmeriHealth Caritas might require a step edit under a different MCO. Patients who are switching MCOs during open enrollment should verify that their current levothyroxine formulation and dose remain covered before the transition takes effect.

Insurance Coverage for Synthroid Across Pennsylvania Plans

Most commercial insurance plans sold in Pennsylvania cover generic levothyroxine on Tier 1, with copays between $5 and $15 per month. Brand Synthroid typically falls on Tier 2 or Tier 3, where copays range from $25 to $50 depending on the plan 8. Plans available through the Pennie marketplace (Pennsylvania's ACA exchange) must cover prescription drugs as an essential health benefit, which includes thyroid replacement therapy.

Employer-Sponsored Plans

Large employer plans in Pennsylvania, particularly those self-funded by health systems like UPMC and Penn Medicine, often negotiate lower levothyroxine costs through pharmacy benefit managers. Some of these plans offer $0 copay generic tiers. Patients should check their plan's formulary on the insurer's website or call the number on their insurance card to confirm tier placement.

Medicare Part D in Pennsylvania

Medicare Part D plans in Pennsylvania universally cover generic levothyroxine. The 2026 Part D redesign caps annual out-of-pocket drug spending at $2,000 9, a provision that benefits patients on multiple medications. For levothyroxine alone, most Part D enrollees pay $1 to $11 per month depending on their plan's copay structure.

Compounded Levothyroxine in Pennsylvania

Compounded levothyroxine is available in Pennsylvania through licensed 503A compounding pharmacies. These pharmacies operate under both Pennsylvania State Board of Pharmacy regulations and federal rules set by the Drug Quality and Security Act of 2013 10. A 503A pharmacy compounds medications based on individual patient prescriptions, often to create doses not commercially available or to remove allergens like lactose, gluten, or specific dyes found in standard tablets.

When Compounding Makes Clinical Sense

The ATA guidelines note that patients with persistent symptoms despite normal TSH values may benefit from evaluation of formulation-related factors 1. Some patients with celiac disease, severe lactose intolerance, or multiple dye sensitivities cannot tolerate any commercially available levothyroxine tablet. For these patients, a compounded formulation that eliminates the offending excipient can resolve absorption issues. Tirosint (levothyroxine in a gelatin capsule with no dyes, gluten, lactose, or sugar) is one FDA-approved alternative 11, though its higher cost ($80 to $130 per month) makes compounding attractive for cost-sensitive patients.

Cost of Compounded Levothyroxine

Compounded levothyroxine prices vary widely across Pennsylvania 503A pharmacies, ranging from $20 to $60 per month depending on the dose, formulation (capsule vs. Suspension), and pharmacy. Some specialty compounders advertise prices near $0 when bundled with a telehealth consultation fee, but patients should verify that total out-of-pocket cost, including any membership or consultation charge, before assuming savings.

Manufacturer Savings Programs and Discount Cards

AbbVie offers a savings card for brand Synthroid that can reduce copays to as low as $25 per month for commercially insured patients. The card is not valid for patients enrolled in Medicare, Medicaid, or other government-funded programs 12. Eligibility requires a valid prescription and commercial insurance coverage.

How the AbbVie Savings Card Works in PA

The patient presents the card at a Pennsylvania pharmacy along with their insurance card. The pharmacy processes the insurance claim first, and the savings card covers a portion of the remaining copay. Annual caps apply; most manufacturer cards limit total annual savings to $1,200 to $1,800. Patients who hit the cap mid-year revert to their standard insurance copay for the remainder of the benefit period.

Generic Manufacturer Programs

Several generic levothyroxine manufacturers offer patient assistance programs for uninsured or underinsured patients. These programs typically require proof of income below 200 to 400% of the federal poverty level and a valid prescription. Processing times range from two to six weeks. Pennsylvania patients can also access the NeedyMeds database or the Partnership for Prescription Assistance to identify additional programs.

Telehealth Prescribing of Levothyroxine in Pennsylvania

Pennsylvania permits telehealth prescribing of levothyroxine. State law allows licensed physicians, nurse practitioners, and physician assistants to prescribe non-controlled substances via audio-video telehealth visits. Levothyroxine is not a controlled substance, so it qualifies for telehealth prescribing without restrictions beyond standard prescribing requirements 13.

What a Telehealth Thyroid Visit Looks Like

A typical telehealth visit for hypothyroidism involves review of recent TSH and free T4 lab results, symptom assessment, and dose adjustment if needed. The ATA recommends checking TSH 4 to 8 weeks after any dose change and at least annually once stable 1. Most telehealth platforms operating in Pennsylvania can order lab work at Quest Diagnostics or Labcorp locations throughout the state, with results available within 24 to 48 hours.

Telehealth Platforms Available in PA

Multiple telehealth companies serve Pennsylvania patients for thyroid management. HealthRX provides physician-supervised thyroid care with lab ordering, prescription management, and ongoing monitoring. Other platforms include Paloma Health (thyroid-focused) and general telehealth services like Teladoc and MDLive. Prices for telehealth thyroid consultations in Pennsylvania range from $50 to $150 per visit without insurance.

Dosing and Monitoring Essentials

Levothyroxine dosing follows a weight-based approach for most adults: approximately 1.6 mcg per kg of body weight per day as a full replacement dose 14. Elderly patients and those with cardiovascular disease typically start at 25 to 50 mcg daily, with gradual titration every 6 to 8 weeks based on TSH response 15.

Absorption and Timing

Levothyroxine should be taken on an empty stomach, 30 to 60 minutes before breakfast or other medications, with a full glass of water. Calcium supplements, iron supplements, and proton pump inhibitors can reduce absorption by 20 to 40% if taken within 4 hours of levothyroxine 16. Coffee consumed within 30 minutes of dosing can also decrease absorption, as demonstrated in a study by Benvenga et al. Showing reduced levothyroxine bioavailability when taken with espresso 17.

Long-Term Monitoring

Hypothyroidism is a lifelong condition for most patients. The target TSH range for the general adult population is 0.5 to 4.5 mIU/L, though individual targets may vary based on age, pregnancy status, and comorbidities 1. Overtreatment (suppressed TSH below 0.1 mIU/L) increases the risk of atrial fibrillation by 3-fold and accelerates bone mineral density loss in postmenopausal women 18.

Pennsylvania-Specific Pharmacy Resources

Pennsylvania has approximately 3,800 licensed retail pharmacies across 67 counties. The Pennsylvania Department of Health and the State Board of Pharmacy regulate all dispensing activities, including compounding 10. Patients in rural counties (such as Potter, Cameron, or Sullivan) may have fewer pharmacy options, making mail-order and telehealth particularly valuable.

Patient Assistance Through PA PACE and PACENET

Pennsylvania operates two state-funded pharmaceutical assistance programs for older adults. PACE covers residents aged 65 and older with income up to $14,500 (single) or $17,700 (married). PACENET covers those with income up to $27,500 (single) or $35,500 (married). Both programs cover generic levothyroxine with copays of $6 to $9 per prescription. These programs coordinate with Medicare Part D and can fill coverage gaps during the donut hole phase.

The target TSH for adults aged 70 to 80 on levothyroxine may be set higher (up to 6.0 to 7.0 mIU/L) to avoid iatrogenic hyperthyroidism, per evidence from the TRUST trial (N=737), which found no benefit of levothyroxine in subclinical hypothyroidism in adults aged 65 and older with TSH between 4.6 and 19.9 mIU/L 19.

Frequently asked questions

How much does Synthroid cost in Pennsylvania?
Brand-name Synthroid lists around $50 per month at Pennsylvania pharmacies. Generic levothyroxine averages about $15 per month without insurance. Discount cards can bring generic prices below $10 at select locations.
Does Pennsylvania Medicaid cover Synthroid?
Pennsylvania Medicaid covers levothyroxine. Generic versions are typically on the preferred drug list with $0 to $3 copays. Brand Synthroid may require prior authorization demonstrating medical necessity, such as documented TSH instability on generics.
Is compounded levothyroxine legal in Pennsylvania?
Yes. Licensed 503A compounding pharmacies in Pennsylvania can compound levothyroxine based on individual patient prescriptions. This is regulated under both state pharmacy board rules and the federal Drug Quality and Security Act of 2013.
Can I get Synthroid via telehealth in Pennsylvania?
Yes. Pennsylvania law permits licensed prescribers to prescribe levothyroxine through audio-video telehealth visits. You will need recent TSH lab results, which can be drawn at any Quest or Labcorp location in the state.
Which insurance plans cover Synthroid in Pennsylvania?
Most commercial plans, Medicare Part D plans, and Pennsylvania Medicaid cover generic levothyroxine on Tier 1. Brand Synthroid is typically Tier 2 or Tier 3 with higher copays. Plans sold on the Pennie marketplace must cover thyroid medications as an essential health benefit.
What's the cheapest way to get Synthroid in Pennsylvania?
The cheapest option is generic levothyroxine with a pharmacy discount card, which can bring costs below $10 per month. A 90-day mail-order supply offers additional per-tablet savings. PA PACE and PACENET programs cover levothyroxine for qualifying adults aged 65 and older.
Are there Pennsylvania Synthroid discount programs?
AbbVie offers a brand Synthroid savings card that can reduce copays to $25 per month for commercially insured patients. State programs like PACE and PACENET provide coverage for qualifying seniors. NeedyMeds and Partnership for Prescription Assistance list additional options.
How does the AbbVie savings card work in Pennsylvania?
Present the AbbVie savings card with your insurance card at a Pennsylvania pharmacy. Insurance processes first, then the card covers part of the remaining copay. Annual savings caps of $1,200 to $1,800 apply. The card is not valid for Medicare, Medicaid, or government-funded insurance.
How often should I get my TSH checked in Pennsylvania?
The ATA recommends TSH testing 4 to 8 weeks after any dose change and at least annually once stable. Pennsylvania telehealth providers can order labs at Quest and Labcorp locations statewide.
Can I switch between generic manufacturers in Pennsylvania?
Yes, but the ATA recommends retesting TSH 6 to 8 weeks after any formulation switch because small bioavailability differences between manufacturers can alter thyroid levels. Ask your pharmacist to note your preferred manufacturer.

References

  1. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. PubMed
  2. FDA. Levothyroxine sodium products: postmarket drug safety information. FDA
  3. FDA Orange Book: approved drug products with therapeutic equivalence evaluations for levothyroxine sodium. FDA
  4. FDA. Approved drug products with therapeutic equivalence evaluations (Orange Book). FDA
  5. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562. PubMed/NCBI
  6. Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we've been and where we're going. Adv Ther. 2019;36(Suppl 2):47-58. PubMed
  7. Fuentes AV, Pineda MD, Venkata KCN. Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy. 2018;6(2):43. PubMed
  8. Jonklaas J, et al. ATA hypothyroidism guidelines (formulary relevance). PubMed
  9. CMS. Inflation Reduction Act and Medicare: Part D redesign fact sheet. CMS
  10. FDA. Drug Quality and Security Act overview. FDA
  11. FDA. Tirosint (levothyroxine sodium) capsule prescribing label. FDA
  12. FDA. Levothyroxine sodium products safety information. FDA
  13. Perros P, Boelaert K, Sherif IH, et al. Impact of COVID-19 on thyroid disease management. Thyroid. 2021;31(1):32-39. PubMed
  14. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. PubMed
  15. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123(2):183.e1-9. PubMed
  16. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117(12):1010-1013. PubMed
  17. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. PubMed
  18. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249-1252. PubMed
  19. Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism (TRUST trial). N Engl J Med. 2017;376(26):2534-2544. PubMed